molecular function |
| GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| GO:0005088 | | Ras guanyl-nucleotide exchange factor activity | | Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase. |
| GO:0016301 | | kinase activity | | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
| GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| GO:0043548 | | phosphatidylinositol 3-kinase binding | | Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring. |
| GO:0046934 | | phosphatidylinositol-4,5-bisphosphate 3-kinase activity | | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+). |
| GO:0004992 | | platelet activating factor receptor activity | | Combining with platelet activating factor to initiate a change in cell activity. |
| GO:0005019 | | platelet-derived growth factor beta-receptor activity | | Combining with platelet-derived growth factor isoform PDGF-BB or PDGF-AB to initiate a change in cell activity. |
| GO:0048407 | | platelet-derived growth factor binding | | Interacting selectively and non-covalently with platelet-derived growth factor. |
| GO:0005161 | | platelet-derived growth factor receptor binding | | Interacting selectively and non-covalently with the platelet-derived growth factor receptor. |
| GO:0005017 | | platelet-derived growth factor-activated receptor activity | | Combining with platelet-derived growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0004672 | | protein kinase activity | | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
| GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| GO:0004713 | | protein tyrosine kinase activity | | Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
| GO:0005102 | | receptor binding | | Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
| GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| GO:0004714 | | transmembrane receptor protein tyrosine kinase activity | | Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate. |
| GO:0038085 | | vascular endothelial growth factor binding | | Interacting selectively and non-covalently with a vascular endothelial growth factor. |
biological process |
| GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| GO:0000165 | | MAPK cascade | | An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
| GO:0035909 | | aorta morphogenesis | | The process in which the anatomical structures of an aorta are generated and organized. An aorta is an artery that carries blood from the heart to other parts of the body. |
| GO:0055003 | | cardiac myofibril assembly | | The process whose specific outcome is the progression of the cardiac myofibril over time, from its formation to the mature structure. A cardiac myofibril is a myofibril specific to cardiac muscle cells. |
| GO:0060326 | | cell chemotaxis | | The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0016477 | | cell migration | | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
| GO:0060981 | | cell migration involved in coronary angiogenesis | | The orderly movement of a cell from one site to another that will contribute to the formation of new blood vessels in the heart from pre-existing blood vessels. |
| GO:0035441 | | cell migration involved in vasculogenesis | | The orderly movement of a cell from one site to another that will contribute to the differentiation of an endothelial cell that will form de novo blood vessels and tubes. |
| GO:0036120 | | cellular response to platelet-derived growth factor stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus. |
| GO:0006935 | | chemotaxis | | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0006024 | | glycosaminoglycan biosynthetic process | | The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars. |
| GO:0048839 | | inner ear development | | The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure. |
| GO:0035556 | | intracellular signal transduction | | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| GO:0072284 | | metanephric S-shaped body morphogenesis | | The process in which the metanephric S-shaped body is generated and organized. The metanephric S-shaped body is the successor of the metanephric comma-shaped body that contributes to the morphogenesis of a nephron in the metanephros. |
| GO:0072278 | | metanephric comma-shaped body morphogenesis | | The process in which the metanephric comma-shaped body is generated and organized. The metanephric comma-shaped body is the precursor structure to the metanephric S-shaped body that contributes to the morphogenesis of a nephron in the metanephros. |
| GO:0072277 | | metanephric glomerular capillary formation | | The process that gives rise to a metanephric glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts. |
| GO:0072262 | | metanephric glomerular mesangial cell proliferation involved in metanephros development | | The multiplication or reproduction of glomerular mesangial cells in the metanephros, resulting in the expansion of the population. |
| GO:0072275 | | metanephric glomerulus morphogenesis | | The process in which the anatomical structures of the metanephric glomerulus are generated and organized. The metanephric glomerulus is a capillary tuft surrounded by Bowman's capsule in nephrons of the vertebrate kidney, or metanephros. |
| GO:0035789 | | metanephric mesenchymal cell migration | | The orderly movement of undifferentiated metanephric mesenchymal cells (precursors to metanephric mesangial cells) from the mesenchyme into the cleft of the developing glomerulus, during development of the metanephros. |
| GO:0072075 | | metanephric mesenchyme development | | The biological process whose specific outcome is the progression of a metanephric mesenchyme from an initial condition to its mature state. This process begins with the formation of metanephric mesenchyme and ends with the mature structure. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros. |
| GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0018108 | | peptidyl-tyrosine phosphorylation | | The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
| GO:0046488 | | phosphatidylinositol metabolic process | | The chemical reactions and pathways involving phosphatidylinositol, any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. |
| GO:0046854 | | phosphatidylinositol phosphorylation | | The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol. |
| GO:0048015 | | phosphatidylinositol-mediated signaling | | A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
| GO:0016310 | | phosphorylation | | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
| GO:0048008 | | platelet-derived growth factor receptor signaling pathway | | The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands. |
| GO:0035791 | | platelet-derived growth factor receptor-beta signaling pathway | | A series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:2000573 | | positive regulation of DNA biosynthetic process | | Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process. |
| GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| GO:0043547 | | positive regulation of GTPase activity | | Any process that activates or increases the activity of a GTPase. |
| GO:0043406 | | positive regulation of MAP kinase activity | | Any process that activates or increases the frequency, rate or extent of MAP kinase activity. |
| GO:0090280 | | positive regulation of calcium ion import | | Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle. |
| GO:0030335 | | positive regulation of cell migration | | Any process that activates or increases the frequency, rate or extent of cell migration. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0038091 | | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | | A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation. |
| GO:0050921 | | positive regulation of chemotaxis | | Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. |
| GO:0032967 | | positive regulation of collagen biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. |
| GO:0035793 | | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | | Any process that increases the frequency, rate or extent of metanephric mesenchymal cell migration as a result of the series of molecular signals generated as a consequence of a platelet-derived growth factor receptor-beta binding to one of its physiological ligands. |
| GO:0045840 | | positive regulation of mitotic nuclear division | | Any process that activates or increases the frequency, rate or extent of mitosis. |
| GO:0043552 | | positive regulation of phosphatidylinositol 3-kinase activity | | Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity. |
| GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| GO:0010863 | | positive regulation of phospholipase C activity | | Any process that increases the rate of phospholipase C activity. |
| GO:0032516 | | positive regulation of phosphoprotein phosphatase activity | | Any process that activates or increases the activity of a phosphoprotein phosphatase. |
| GO:2000379 | | positive regulation of reactive oxygen species metabolic process | | Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. |
| GO:0014911 | | positive regulation of smooth muscle cell migration | | Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration. |
| GO:0048661 | | positive regulation of smooth muscle cell proliferation | | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
| GO:0046777 | | protein autophosphorylation | | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
| GO:0006468 | | protein phosphorylation | | The process of introducing a phosphate group on to a protein. |
| GO:0032956 | | regulation of actin cytoskeleton organization | | Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
| GO:0014066 | | regulation of phosphatidylinositol 3-kinase signaling | | Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| GO:0043627 | | response to estrogen | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
| GO:0034405 | | response to fluid shear stress | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface. |
| GO:0042542 | | response to hydrogen peroxide | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
| GO:0055093 | | response to hyperoxia | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating increased oxygen tension. |
| GO:0033993 | | response to lipid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus. |
| GO:0014070 | | response to organic cyclic compound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
| GO:0032526 | | response to retinoic acid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
| GO:0009636 | | response to toxic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus. |
| GO:0061298 | | retina vasculature development in camera-type eye | | The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure. |
| GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| GO:0071670 | | smooth muscle cell chemotaxis | | The directed movement of a smooth muscle cell in response to an external stimulus. |
| GO:0007169 | | transmembrane receptor protein tyrosine kinase signaling pathway | | A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription. |
| GO:0042060 | | wound healing | | The series of events that restore integrity to a damaged tissue, following an injury. |
cellular component |
| GO:0016324 | | apical plasma membrane | | The region of the plasma membrane located at the apical end of the cell. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0031410 | | cytoplasmic vesicle | | A vesicle found in the cytoplasm of a cell. |
| GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| GO:0031226 | | intrinsic component of plasma membrane | | The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane. |
| GO:0043202 | | lysosomal lumen | | The volume enclosed within the lysosomal membrane. |
| GO:0005764 | | lysosome | | A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |